This is to inform you that the Board of Directors of the Company, at its meeting held on November 12, 2025, considered and approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter and six months ended September 30, 2025 ( Unaudited Financial Results ). The said results were duly submitted to the stock exchanges on the same day.For ease of reference and enhanced clarity, the Unaudited Financial Results along with the Limited Review Report thereon are being made available herewith in a more legible format.
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter and six months ended September 30, 2025 at its meeting on November 12, 2025. These results were originally submitted to the stock exchanges on the same day. The current filing is a re-submission of the same results along with the Limited Review Report, presented in a clearer, more readable format for investors.
This is an administrative re-filing and does not contain any new financial information or change in reported numbers. Investors should refer to the originally submitted results dated November 12, 2025 for the actual Q2/H1 FY26 performance metrics.